Cancer research
The brain cancer market is experiencing a significant shift towards targeted therapies and immunotherapy approaches, driven by the discovery of genetic markers and biomarkers associated with brain tumors. This transition is expected to lead to more precision medicine strategies and innovative treatments that can effectively target brain cancer while preserving
Cancer research
Researchers at Oregon Health and Science University (OHSU) have made significant progress in understanding the treatment of head and neck squamous cell carcinoma (HNSCC), a type of cancer that affects millions globally. Despite the availability of only a few FDA-approved treatments, scientists have employed high-throughput inhibitor assays and computational tools
Cancer research
Lung cancer, the most common histological subtype of lung cancer, demonstrates significant intertumoral heterogeneity. Recent research from Tianjin University has shed new light on the role of dendritic cells in understanding lung adenocarcinoma and developing more effective immunotherapy strategies. The study, published in Frontiers in Immunology, has identified a novel
Cancer research
A new study published in Discovery Medicine highlights the potential of immunotherapy in treating microsatellite instability-high (MSI-H) colon cancer, a subtype of colon cancer characterized by a high number of genetic mutations. According to the research, MSI-H colon cancer accounts for nearly 10% of all cancer diagnoses annually and is
Cancer research
Cancer researchers at the University of Guelph in Canada have made significant advancements in understanding the impact of dendritic cell-based cancer vaccines on host innate lymphoid cells (ILCs). The study sheds light on the complex relationship between these vaccines and ILCs, which plays a crucial role in anti-tumor efficacy. According
Cancer
Researchers at the Francis Crick Institute have published a new study on the relationship between circulating tumor DNA (ctDNA) and blood tumor mutational burden (bTMB) in patients with metastatic solid tumors treated with atezolizumab. The study found that molecular response (MR) to atezolizumab, measured by a 50% decrease in ctDNA
Cancer
Recent research published in the Molecular Therapy Oncology journal has highlighted the potential of oncolytic adenoviruses in treating a wide range of tumors. According to the study, these viruses have shown to be effective in hijacking cellular machinery and influencing the acetylome of the host genome. The researchers from the
Cancer
Cancer researchers have long been exploring innovative approaches to combat cancer, and a recent patent application by Abate-Daga, Daniel, and Mule, James, offers a promising advancement in this field. The invention proposes the use of chimeric antigen receptor tumor infiltrating lymphocytes (CAR-TILs) to target and kill cancer cells, including solid
Cancer
Researchers from Shandong Cancer Hospital and Institute have published a new study highlighting the potential of immune checkpoint inhibitors (ICIs) in cancer treatment. According to the research, ICIs have revolutionized cancer treatment by harnessing the body's immune system to eliminate cancer cells. However, the efficacy of ICIs significantly
Cancer
Research from Northeastern University has shed new light on the complex relationship between fungi and cancer, revealing that fungal infections can significantly contribute to tumor growth, metastasis, and immune escape. The study, published in Frontiers in Cellular and Infection Microbiology, highlights the multifaceted role of fungal infections in tumor biology
Cancer
Scientists at Bengbu Med Univ have made groundbreaking advancements in biotechnology, specifically in the field of cancer gene therapy. By leveraging cutting-edge nanotechnology, researchers have developed sophisticated nanomaterials that accurately control and target nitric oxide (NO) delivery, overcoming its inherent limitations. This innovative approach has shown significant promise in treating
Cancer research
Current study results on gastric cancer have been published, highlighting the impact of tertiary-lymphoid-structure-related genes on the clinical prognosis and tumor immune environment of patients with gastric cancer. The research involved analyzing The Cancer Genome Atlas data and identifying 23 differentially expressed genes associated with the tumor microenvironment. These findings
